Respiri Limited (AU:RSH) has released an update.
Respiri Limited reports a significant increase in patient enrolment for its respiratory healthcare management programs, with a 353% rise to 1,423 active patients, leading to higher expected revenues. The company doubled its healthcare organization customers and noted a record quarter for invoiced recurring revenues. With the success of its Clinic in Cloud program and new partnerships, Respiri is on track for continued growth and anticipates reaching its break-even target by late 2024.
For further insights into AU:RSH stock, check out TipRanks’ Stock Analysis page.
